483
New York Reproductive Wellness Medicine, P.C. d.b.a. Oma Labs Long Island, L.L.CFDA 483 - New York Reproductive Wellness Medicine, P.C. d.b.a. Oma Labs Long Island, L.L.C - April 07, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of New York Reproductive Wellness Medicine, P.C. d.b.a. Oma Labs Long Island, L.L.C in Syosset, NY, identified two significant observations. The firm failed to ensure HCT/P donor eligibility was determined based on complete screening and testing results, specifically for an anonymous oocyte donor. Additionally, accompanying records for anonymous HCT/P donors contained personal identifying information, which is a concern for donor anonymity.
- Inspection Date
- April 7, 2023
- Product Type
- Biologics
Open in Dashboard
ID · 38258d05-6225-4389-9dc1-8eca46603a9e